Lighthizer hears first-term Democrats' concerns about USMCA’s biologics provisions

Several first-term Democrats on Tuesday told U.S. Trade Representative Robert Lighthizer that biologics provisions in the U.S.-Mexico-Canada Agreement run counter to their goal of lowering drug prices in the U.S. Lighthizer met with the first-term Democrats on Capitol Hill on Tuesday to discuss USMCA. Lawmakers in attendance told Inside U.S. Trade the deal’s drug provisions were a key topic of conversation. USMCA would require Canada and Mexico to provide 10 years of data exclusivity for biologics. Canadian law...